miR-125b-5p Suppresses Leukemia Cell Proliferation by Regulating MCL1

被引:0
|
作者
Zhou, Yan [1 ]
Zhu, Huan [1 ]
Han, Jinan [1 ]
Xu, Ying [1 ]
Wang, Dan [1 ]
Jin, Wen [1 ]
Zhu, Ruyuan [1 ]
Qiao, Lixing [1 ,2 ]
机构
[1] Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Dept Pediat, 87 Dingjiaqiao,Hunan Rd, Nanjing 210009, Jiangsu, Peoples R China
关键词
miR-125b-5p; MCL1; leukemia; proliferation; apoptosis; INHIBITS APOPTOSIS; EXPRESSION DATA;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Leukemia threatens children's health, and leukemia cell proliferation and apoptosis participate in the regulation of leukemia. The current study aims to probe into the miR-125b-5p biological function in regulating leukemia cell proliferation and apoptosis by myeloid cell leukemia 1 (MCL1). Quantitative real-time polymerase chain reaction was conducted to quantify miR-125b-5p expression in leukemia cells. Cell transfection, cell-counting assay 8, Western blot, and flow cytometry assays were applied to assess the miR-125b-5p function in leukemia. A dual-luciferase reporter gene assay was applied to investigate the mechanism. miR-125b-5p was lessened in leukemia cells, and the increased miR125b-5p repressed leukemia cell proliferation and boosted apoptosis. Further, miR-125b-5p could bound with the MCL1 3'-untranslated region and regulated its expression. Furthermore, the elevated expression of miR-125b-5p repressed leukemia cell proliferation and boosted apoptosis through downregulating MCL1. miR-125b-5p inhibited leukemia cell proliferation and boosted apoptosis through decreasing MCL1.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
  • [11] MiR-125b-5p and miR-181b-5p inhibit keratinocyte proliferation in skin by targeting Akt3
    Zheng, Yunpeng
    Cai, Bingjie
    Li, Xuyang
    Li, Dongqin
    Yin, Guangwen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 862
  • [12] Knockdown of miR-125b-5p inhibits the proliferation and invasion of gastric carcinoma cells by targeting RYBP
    Jin, Fu-E
    Xie, Bo
    Xian, Hong-Zhen
    Wang, Ji-Hai
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2021, 37 (10) : 863 - 871
  • [13] MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells
    Wang, Yuezhen
    Fang, Jun
    Gu, Feiying
    MOLECULAR BIOTECHNOLOGY, 2022, 64 (09) : 1003 - 1012
  • [14] MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2
    Hui, Lian
    Zhang, Jingru
    Guo, Xing
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1194 - 1201
  • [15] Downregulation of Circ-CEP128 Enhances the Paclitaxel Sensitivity of Cervical Cancer Through Regulating miR-432-5p/MCL1
    Zhao, Ying
    Lan, Yi
    Chi, Yugang
    Yang, Boping
    Ren, Chunyan
    BIOCHEMICAL GENETICS, 2022, 60 (06) : 2346 - 2363
  • [16] Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
    Xulei Huo
    Ke Wang
    Bohan Yao
    Lairong Song
    Zirun Li
    Wenyan He
    Yiming Li
    Junpeng Ma
    Liang Wang
    Zhen Wu
    BMC Cancer, 23
  • [17] Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
    Huo, Xulei
    Wang, Ke
    Yao, Bohan
    Song, Lairong
    Li, Zirun
    He, Wenyan
    Li, Yiming
    Ma, Junpeng
    Wang, Liang
    Wu, Zhen
    BMC CANCER, 2023, 23 (01)
  • [18] Circular RNA GLI2 promotes osteosarcoma cell proliferation, migration, and invasion by targeting miR-125b-5p
    Li, Ji-Feng
    Song, Yu-Ze
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 8
  • [19] miR-26a-5p and miR-125b-5p affect trophoblast genes and cell functions important during early pregnancy†
    Szuszkiewicz, Joanna
    Nitkiewicz, Anna
    Drzewiecka, Klaudia
    Kaczmarek, Monika M.
    BIOLOGY OF REPRODUCTION, 2022, 107 (02) : 590 - 604
  • [20] Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma
    Huang, Shu-Ping
    Jiang, Yi-Fan
    Yang, Lin-Jie
    Yang, Jie
    Liang, Mei-Ting
    Zhou, Hua-Fu
    Luo, Jiao
    Yang, Ping
    Mo, Wei-Jia
    Chen, Gang
    Shi, Lin
    Gan, Ting-Qing
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (02) : 125 - 140